Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral Adrenoleukodystrophy

NCT05819866 is registered in ClinicalTrials.gov with Minoryx Therapeutics, S.L. as lead sponsor.

NCT NCT05819866
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05819866 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral Adrenoleukodystrophy
Lead sponsor
Minoryx Therapeutics, S.L.
Phase
Phase 3
Overall status
Active, not recruiting
Start date
July 12, 2023
Completion date
May 31, 2027
Enrollment
40 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral adrenoleukodystrophy (cald)